<DOC>
	<DOC>NCT00210054</DOC>
	<brief_summary>The purpose of this trial is to characterize the pharmacokinetics of INS37217 following intravenous administration.</brief_summary>
	<brief_title>A Pharmacokinetic Evaluation Study in Healthy Volunteers</brief_title>
	<detailed_description />
	<criteria>are nonsmokers or those subjects whom have not smoked within 6 months are within 20% of their ideal body weight are healthy on the basis of a pretrial physical examination history or suspicion of recent alcohol, barbiturate, amphetamine or narcotic abuse or a positive urine drug test at study screening history of cardiac arrhythmias, bronchospastic or cardiovascular disease, diabetes mellitus, thyrotoxicosis, Parkinsonism, or drug allergy use of concomitant medication other than hormonal contraceptives and multivitamins donation of blood in the 60 days preceding the screening visit have been diagnosed with HIV, hepatitis B or hepatitis C</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>